Cargando…
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
BACKGROUND: Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 + 1 scheme at 2 and 4 months (primary immuniza...
Autores principales: | Hong, Eva, Terrade, Aude, Denizon, Mélanie, Aouiti-Trabelsi, Myriam, Falguières, Michaël, Taha, Muhamed-Kheir, Deghmane, Ala-Eddine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325224/ https://www.ncbi.nlm.nih.gov/pubmed/34330228 http://dx.doi.org/10.1186/s12879-021-06440-w |
Ejemplares similares
-
Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022) -
The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection
por: Antunes, Ana, et al.
Publicado: (2016) -
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
por: Taha, Samy, et al.
Publicado: (2022) -
Differential expression of hemoglobin receptor, HmbR, between carriage and invasive isolates of Neisseria meningitidis contributes to virulence: lessons from a clonal outbreak
por: Sevestre, Julien, et al.
Publicado: (2018) -
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries
por: Taha, Muhamed-Kheir, et al.
Publicado: (2020)